Literature DB >> 32950637

Molecular characterization of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae ST11 harbouring blaNDM-1 and blaOXA-48 carbapenemases in Iran.

Hamid Solgi1, Fereshteh Shahcheraghi2, Negin Bolourchi2, Ali Ahmadi3.   

Abstract

Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) has been increasingly reported and is now recognized as a public health concern. The aim of this study was to investigate the molecular epidemiology of CR-hvKp strains that were isolated from an Iranian hospital. A total of 74 non-duplicated carbapenem-resistant K. pneumoniae (CR-Kp) were collected from patients' clinical or surveillance cultures. Resistance/virulence genes were identified by PCR and sequencing. String test, capsular genotyping, conjugation assays, PCR-based replicon typing, pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST) and were performed. All 74 CR-Kp isolates were carbapenemase producers, which co-carried multiple resistance genes such as blaCTX-M-15, blaTEM-1, blaSHV-type, qnrB1, and qnrS1. The most common carbapenemase gene was blaOXA-48 (67/74 90.5%), followed by blaNDM-1 (18/74 24.3%), and blaNDM-7 (3/74 4%). The blaOXA-48 and blaNDM-1 were found on IncL/M and IncFII conjugative plasmids, respectively. Of 74 CR-Kp isolates, 49 were positive for string test. Capsular genotyping revealed that 34 and 10 CR-Kp strains belonged to the K1 and K2 serotypes, respectively. rmpA was the most prevalent virulence gene detected in 64.8% of the isolates. Fifty two strains were identified as CR-hvKp. PFGE typing showed 5 different clusters with two major clusters B (39 isolates, 52.7%) associated with sequence type 11 (ST11), and A (21 isolates, 28.4%) associated with ST893. Furthermore, ST147, ST392, and ST15 carbapenemase producers have also been sporadically identified. One isolate belonging to ST11 was resistant to colistin and were negative for mcr-1-2-3 genes. Insertional inactivation of mgrB due to IS elements was observed in the colistin-resistant isolate. Our findings suggest that ST11 CR-hvKP strain has a clonal distribution in our hospital. Therefore, immediate implementation of infection-control measures may be the best way to prevent the spread of these clones.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbapenem-resistant; Hypervirulent Klebsiella pneumoniae; MLST; PFGE; ST11

Mesh:

Substances:

Year:  2020        PMID: 32950637     DOI: 10.1016/j.micpath.2020.104507

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  12 in total

1.  Molecular Epidemiology of Hypervirulent K. pneumoniae and Problems of Health-Care Associated Infections.

Authors:  A V Tutelyan; D S Shlykova; Sh L Voskanyan; A M Gaponov; V M Pisarev
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.737

Review 2.  New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams.

Authors:  Juan C Vázquez-Ucha; Jorge Arca-Suárez; Germán Bou; Alejandro Beceiro
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

3.  Emergence of Colistin Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Under the Pressure of Tigecycline.

Authors:  Yawei Zhang; Xiaojuan Wang; Shifu Wang; Shijun Sun; Henan Li; Hongbin Chen; Qi Wang; Hui Wang
Journal:  Front Microbiol       Date:  2021-12-01       Impact factor: 5.640

4.  Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.

Authors:  Negin Bolourchi; Fereshteh Shahcheraghi; Christian G Giske; Shoeib Nematzadeh; Narjes Noori Goodarzi; Hamid Solgi; Farzad Badmasti
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-10-23       Impact factor: 3.944

5.  Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria.

Authors:  Ayorinde O Afolayan; Anderson O Oaikhena; Aaron O Aboderin; Olatunde F Olabisi; Adewale A Amupitan; Oyekola V Abiri; Veronica O Ogunleye; Erkison Ewomazino Odih; Abolaji T Adeyemo; Adeyemi T Adeyemo; Temitope O Obadare; Monica Abrudan; Silvia Argimón; Sophia David; Mihir Kekre; Anthony Underwood; Abiodun Egwuenu; Chikwe Ihekweazu; David M Aanensen; Iruka N Okeke
Journal:  Clin Infect Dis       Date:  2021-12-01       Impact factor: 9.079

6.  The face of hypervirulent Klebsiella pneumoniae isolated from clinical samples of two Iranian teaching hospitals.

Authors:  Rahimeh Sanikhani; Mohammad Moeinirad; Hamid Solgi; Azar Hadadi; Fereshteh Shahcheraghi; Farzad Badmasti
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-08-31       Impact factor: 3.944

7.  Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.

Authors:  Samaneh Pourajam; Elham Kalantari; Hamid Talebzadeh; Hamid Mellali; Ramin Sami; Forogh Soltaninejad; Babak Amra; Mahdi Sajadi; Malihe Alenaseri; Forough Kalantari; Hamid Solgi
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 5.293

Review 8.  Klebsiella species: Taxonomy, hypervirulence and multidrug resistance.

Authors:  Ning Dong; Xuemei Yang; Edward Wai-Chi Chan; Rong Zhang; Sheng Chen
Journal:  EBioMedicine       Date:  2022-04-08       Impact factor: 11.205

9.  Clinical and Molecular Characteristics of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Isolates in a Tertiary Hospital in Shanghai, China.

Authors:  Cong Zhou; Qiang Wu; Leqi He; Hui Zhang; Maosuo Xu; Baoyu Yuan; Zhi Jin; Fang Shen
Journal:  Infect Drug Resist       Date:  2021-07-14       Impact factor: 4.003

10.  Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Klebsiella pneumoniae Strain 52145, and Identification of Its Functional Depolymerase.

Authors:  Botond Zsombor Pertics; Alysia Cox; Adrienn Nyúl; Nóra Szamek; Tamás Kovács; György Schneider
Journal:  Microorganisms       Date:  2021-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.